[Auremn-l] Fwd: Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories

Wed Jan 16 17:37:47 GMT 2019

Prezados membros da AUREMN,

A Bruker em parceria com a AUREMN gostaria de divulgar para a comunidade de
RMN o webinar abaixo. O tema central desse webinar é aplicação da RMN na
industria farmacêutica e utilização de laboratórios de RMN de acesso aberto
(open facilities).

Para essa tarefa foram designados dois pesquisadores, Dra. Anna Codina
(Bruker) e Dr. Mark T. Zell (Takeda)  com destacada atuação na área.

Esperamos que esse webinar venha auxiliar a comunidade de RMN no
desenvolvimento de suas atividades de pesquisa e prestação de serviços

Um excelente webinar a todos!

Abs

Diretoria Multinuclear

Improved Open-Access NMR for the Synthetic and Analytical Chemistry
Laboratories

View in your browser
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct0_0/1?sid=TV2%3A0pJipQZWM>
Webinar Invitation

Innovation with Integrity

<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct1_0/1?sid=TV2%3A0pJipQZWM>

[image: Banner]

Improved Open-Access NMR for the Synthetic and Analytical Chemistry
Laboratories

February 12th 2019

Simplified Walk-up NMR and the Information it can provide

NMR can nowadays be deployed to an open access environment in the chemistry
and analytical laboratories. Reduced footprint NMR instruments are no
longer installed in the basement, but in any floor, surrounded by other
analytical instrumentation, fume cupboards and benches. Improved software
makes data acquisition and processing of complex samples and experiments
straightforward for even novice users. This webinar will illustrate:

   - Examples of NMR instrumentation in walk-up labs
   - Applications of the open access NMR for pharmaceutical chemical and
   analytical R&D
   - Benefits and return of investment of the open access NMR

The recorded version will be sent to all registrants shortly after the live
sessions. Don’t miss it!

Kind regards
Your Webinar team
When and Where

*February 12th 2019* - 11 AM EDT

*Register for this webinar*
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct2_0/1?sid=TV2%3A0pJipQZWM>

*Dr. Anna Codina*

Director Pharmaceutical Business Unit, Bruker BioSpin

*Dr. Mark T. Zell*

Associate Scientific Fellow and Structural Characterization Team Leader,
Takeda

© 2018 Bruker Corporation [image: LinkedIn]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct3_0/1?sid=TV2%3A0pJipQZWM>[image:
Twitter]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct4_0/1?sid=TV2%3A0pJipQZWM>[image:
Facebook]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct5_0/1?sid=TV2%3A0pJipQZWM>[image:
YouTube]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct6_0/1?sid=TV2%3A0pJipQZWM>[image:
Google+]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct7_0/1?sid=TV2%3A0pJipQZWM>[image:
RSS]
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct8_0/1?sid=TV2%3A0pJipQZWM>

Edit your profile
<http://mc.bruker.com/acton/rif/5109/s-0ce7-1812/-/l-1cb19:b/l-1cb19/zout?sid=TV2%3A0pJipQZWM>
Forward
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct9_0/1?sid=TV2%3A0pJipQZWM>
Website
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct1_1/1?sid=TV2%3A0pJipQZWM>
Subscribe
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct10_0/1?sid=TV2%3A0pJipQZWM>

You have been sent this email as a valuable contact of Bruker BioSpin. We
at Bruker take data protection seriously.* Click here to view our updated
Privacy & Cookies Policy
<https://mc.bruker.com/acton/ct/5109/s-0ce7-1812/Bct/l-1cb19/l-1cb19:b/ct11_0/1?sid=TV2%3A0pJipQZWM>*.
Bruker complies with the new General Data Protection Regulation (GDPR). We
are committed to keeping our customers informed and would like to share
news with you. If you feel at any time that your needs have changed and you
no longer wish to receive these news, then you can unsubscribe from these
communications *click here to opt out
<http://a34635.actonsoftware.com/acton/rif/5109/s-0ce7-1812/-/l-1cb19:b/l-1cb19/zout?sid=TV2%3A0pJipQZWM>.
<http://a34635.actonsoftware.com/acton/rif/5109/s-0ce7-1812/-/l-1cb19:b/l-1cb19/zout?sid=TV2%3A0pJipQZWM>*

Bruker Corporation | 15 Fortune Drive | MA 01821 Billerica | Massachusetts
| United States

-- 

Prof. Dr. Cláudio F. Tormena
Chemistry Institute -  University of Campinas
Campinas - SP - Brazil
Phone: +55-19-3521-2092
PO Box 6154 Post Code 13083-970
skype: claudio.francisco.tormena
http://www.pocl.iqm.unicamp.br/
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://auremn.org/pipermail/auremn-l_auremn.org/attachments/20190116/9360267a/attachment-0001.html>